Latest News
2022
Eurofins Discovery Announces Acquisition of DiscoveryBioMed – July 5, 2022
Eurofins enhances its clinical and BioPharma service offering in Japan with immune repertoire analysis technology through the acquisition of Repertoire Genesis Inc. – May 31, 2022
2021
Eurofins Bioanalytical Services develops surrogate virus neutralising antibody detection assays against SARS-CoV-2
Eurofins Viracor BioPharma partners with Moderna, performing essential clinical trial testing for COVID-19 Vaccine
Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world – February 2, 2021
Best in Class Performance for COVID-19 Testing Solutions Case Study
Virus Neutralizing antibody detection assays against COVID-19
Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations – January 6, 2021
2020
Eurofins launches COVID-19 PCR tests with at-home self-sampling options in Europe and donates sequencing capacity to identify VUI-2020-12/01 strain reported to spread faster in the UK – December 23, 2020
Eurofins U.S. Clinical Diagnostic Laboratories Partner with Insurance Providers to Cover FDA-Authorized At-Home COVID-19 Test – December 7, 2020
Eurofins providing COVID-19 analytical testing and services for Pennsylvania Long Term Care Facilities and vulnerable population citizens – August 17, 2020
Eurofins Clinical Diagnostics Launches Lower Cost Highly Accurate COVID-19 PCR Test – August 5, 2020
Eurofins Technologies launches reagents for automated extraction of genomic SARS-CoV-2 RNA from clinical swab samples – August 4, 2020
New Technology to Accommodate Today’s High-Science Study Requirements
Eurofins publishes method for early detection of asymptomatic SARS-CoV-2 virus spreaders, that does not require human PCR clinical testing – July 1, 2020
Eurofins Launches Eurofins SAFER@WORK™: a Comprehensive Suite of Risk-Based COVID-19 Safety Solutions for Businesses – May 29, 202o
Eurofins Technologies launches multiplex Real-Time PCR assay for SARS-CoV-2 (coronavirus) pathogen detection – May 7, 2020
Eurofins scientists develop multiple new solutions to support the world’s fight against the COVID-19 pandemic – ramping up production to enable over 20 million patients tests per month by end May 2020 Activity shows strong resilience in Q1 2020 – April 28, 2020
Eurofins Technologies launches multiple CE-IVD marked serologic products for the detection of antibodies in patients who have been exposed to SARS-CoV-2 (COVID-19) – April 17, 2020
Eurofins Genomics launches “SARS-CoV-2 Full-length Genome Sequencing” service to support researchers globally in their fight against the COVID-19 pandemic and outbreak source tracing – April 16, 2020
Eurofins Technologies launches multiple new products for the serologic detection of antibodies in patients who have been exposed to COVID-19 – April 9, 2020
Eurofins Scientific Offers a full range of Testing services for Personal Protective Equipment (PPEs) and Medical Devices used in the fight against the COVID pandemic – April 6, 2020
Eurofins Technologies launches testing solutions for the detection of SARS-CoV-2 on environmental surfaces – March 27, 2020
Eurofins Scientific Supports Healthcare Authorities in Europe, the U.S.A. and Brazil in their Fight against the COVID-19 Pandemic with Additional Testing Options and Fast Growing Capacity – March 19, 2020
Eurofins Supports SARS-CoV-2 Analyses – March 12, 2020
Eurofins delivers strong growth again in 2019 – March 4, 2020
